Kimihide Himuro

Publications (3)1.58 Total impact

• Article: [Case report; typical MR image findings in Japanese encephalitis; a case report].

  Mitsuhiro Sakamoto, Noriko Hayashi, Yoshimi Nakamura, Kimihide Himuro
  Nihon Naika Gakkai Zasshi 08/2011; 100(8):2256-8.
• Article: Reversible posterior leukoencephalopathy syndrome: a possible manifestation of Wegener's granulomatosis-mediated endothelial injury.

  Minako Nishio, Katsunobu Yoshioka, Keiko Yamagami, Takashi Morikawa, Yoshio Konishi, Noriko Hayashi, Kimihide Himuro, Masahito Imanishi
  [show abstract] [hide abstract]
  ABSTRACT: We present the case of a 15-year-old girl who had Wegener's granulomatosis with severe intestinal involvement. During the clinical course, she developed generalized seizures and was diagnosed with reversible posterior leukoencephalopathy syndrome (RPLS). Plasma exchange combined with steroid pulse therapy was initiated and showed marked improvement. This is one of the few cases of RPLS without severe hypertension or renal failure, suggesting that RPLS is likely to be a manifestation of Wegener's granulomatosis-mediated endothelial injury.
  Modern Rheumatology 02/2008; 18(3):309-14. · 1.58 Impact Factor
• Article: [Chronic GVHD with polymyositis after non-myeloablative stem cell transplantation].

  Hirohisa Nakamae, Kimihide Himuro, Kiyoyuki Hagihara, Yoshiki Terada, Erina Sakamoto, Yasunobu Takeoka, Takahiko Nakane, Mika Nakamae, Kensuke Ohta, Takahisa Yamane, Hiroyuki Shimada, Takami Miki, Masayuki Hino
  [show abstract] [hide abstract]
  ABSTRACT: A 57-year-old man underwent an autologous hematopoietic stem cell transplant for mantle cell lymphoma in August 1999. Anemia and thrombocytopenia appeared in November 2001. He was diagnosed with further hematological examination as having acute myeloid leukemia with multilineage dysplasia following secondary myelodysplastic syndrome. He received the allogeneic hematopoietic stem cell transplant from his HLA DRB1 locus mismatched brother in May 2002. The nonmyeloablative preparative regimen consisted of fludarabine 30mg/m2 for 6 days and busulfan 4mg/kg for 2 days. Eosinophilia, decrease of lacrimal fluid and liver dysfunction appeared on Day 104. We diagnosed this as chronic GVHD and treated the patient with prednisolone 10 mg/day. Thereafter, his chronic GVHD gradually improved. He had fever and myalgia in the extremities and lumbar region with elevated serum CPK and aldolase in January 2003. Histological examination led to a diagnosis of polymyositis simultaneously with chronic GVHD. Prednisolone 50 mg/day as an initial dose was started for the polymyositis following which the prednisolone dose was gradually tapered off. The polymyositis improved promptly after the administration of prednisolone and remains in remission with a current maintenance program of prednisolone 5 mg/day.
  [Rinshō ketsueki] The Japanese journal of clinical hematology 12/2005; 46(11):1213-7.